Overview

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Status:
Recruiting

Trial end date:
2022-01-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo in participants with moderate to severe plaque psoriasis in mainland China, Taiwan, and South Korea

Phase:

Phase 3

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

BMS-986165